These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25095499)

  • 21. The Urogenital Epithelium and Corporal Tissues Are the Primary Targets of Rejection in Penile Vascularized Composite Allotransplantation: A New Real-Time Tissue-Based Monitoring System.
    Lough DM; Sopko NA; Matsui H; Miller D; Swanson EW; Bluebond-Langner R; Brandacher G; Burnett AL; Bivalacqua TJ; Redett RJ
    Plast Reconstr Surg; 2019 Mar; 143(3):534e-544e. PubMed ID: 30817651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Composite Graft Pretreatment With Hydrogen Sulfide Delays the Onset of Acute Rejection.
    Fries CA; Lawson SD; Wang LC; Spencer JR; Roth M; Rickard RF; Gorantla VS; Davis MR
    Ann Plast Surg; 2019 Apr; 82(4):452-458. PubMed ID: 30628928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is Skin the Most Allogenic Tissue in Vascularized Composite Allotransplantation and a Valid Monitor of the Deeper Tissues?
    Robbins NL; Wordsworth MJ; Parida BK; Kaplan B; Gorantla VS; Weitzel EK; Breidenbach WC
    Plast Reconstr Surg; 2019 Apr; 143(4):880e-886e. PubMed ID: 30921156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tolerance Induction in Vascularized Composite Allotransplantation-A Brief Review of Preclinical Models.
    Huelsboemer L; Kauke-Navarro M; Reuter S; Stoegner VA; Feldmann J; Hirsch T; Kueckelhaus M; Dermietzel A
    Transpl Int; 2023; 36():10955. PubMed ID: 36846605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes after hand and upper extremity transplantation.
    Shores JT; Malek V; Lee WPA; Brandacher G
    J Mater Sci Mater Med; 2017 May; 28(5):72. PubMed ID: 28361279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trauma-induced Rejection in Vascularized Composite Allotransplantation.
    Etra JW; Shores JT; Sander IB; Brandacher G; Lee WPA
    Ann Surg; 2020 May; 271(5):e113-e114. PubMed ID: 31090564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascularized Composite Allotransplantation: eResources.
    Edmondson SJ; Issa F
    Transplantation; 2016 Jul; 100(7):1392-3. PubMed ID: 27326808
    [No Abstract]   [Full Text] [Related]  

  • 28. Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockade.
    Foster RD; Pham S; Li S; Aitouche A
    Transplantation; 2003 Sep; 76(6):988-94. PubMed ID: 14508367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The future of immunotherapy for composite tissues allotransplantation].
    Petit F
    Ann Chir Plast Esthet; 2007 Oct; 52(5):502-8. PubMed ID: 17651884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Could Sentinel Skin Transplants Have Some Utility in Solid Organ Transplantation?
    Ali JM; Catarino P; Dunning J; Giele H; Vrakas G; Parmar J
    Transplant Proc; 2016 Oct; 48(8):2565-2570. PubMed ID: 27788782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Advent of Vascularized Composite Allotransplantation.
    Cetrulo CL; Ng ZY; Winograd JM; Eberlin KR
    Clin Plast Surg; 2017 Apr; 44(2):425-429. PubMed ID: 28340673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BASIC PRINCIPLES OF MODELLIND OF FACIAL COMPOSITE TISSUE ALLOGRAFTS.
    Volokh MA; Lesnyakov AF; Kikoriya NG; Romanova ES; Volokh SA
    Vestn Khir Im I I Grek; 2016; 175(2):60-5. PubMed ID: 30427150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mucosa and Rejection in Facial Vascularized Composite Allotransplantation: A Systematic Review.
    Kauke M; Safi AF; Zhegibe A; Haug V; Kollar B; Nelms L; Palmer WJ; Tchiloemba B; Lian CG; Murphy GF; Pomahac B
    Transplantation; 2020 Dec; 104(12):2616-2624. PubMed ID: 32053572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abdominal Wall Transplant Surgery.
    Park SH; Eun SC
    Exp Clin Transplant; 2018 Dec; 16(6):745-750. PubMed ID: 30373506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical facial composite tissue allotransplantation: a review of the first four global experiences and future implications.
    Hui-Chou HG; Nam AJ; Rodriguez ED
    Plast Reconstr Surg; 2010 Feb; 125(2):538-546. PubMed ID: 20124840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunosuppression maintenance in vascularized composite allotransplantation: what is just right?
    Howsare M; Jones CM; Ramirez AM
    Curr Opin Organ Transplant; 2017 Oct; 22(5):463-469. PubMed ID: 28759463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
    Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
    Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perioperative management of penile transplantation.
    Tiftikcioglu YO; Erenoglu CM; Lineaweaver WC; Zhang F
    Microsurgery; 2016 May; 36(4):271-5. PubMed ID: 26890382
    [No Abstract]   [Full Text] [Related]  

  • 39. Current status of composite tissue allotransplantation.
    Siemionow M; Bozkurt M; Kulahci Y
    Handchir Mikrochir Plast Chir; 2007 Jun; 39(3):145-55. PubMed ID: 17602375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Swine hemi-facial composite tissue allotransplantation: a model to study immune rejection.
    Kuo YR; Shih HS; Lin CC; Huang CC; Yang JC; Wu WS; Goto S; Chen CL; Lee WP
    J Surg Res; 2009 May; 153(2):268-73. PubMed ID: 18708190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.